Multisite Implementation of COMPRENDO

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Sep 19, 2023

Keywords

ClinConnect Summary

The COMPRENDO study is exploring a new way to help families of Hispanic children with cancer navigate the clinical trial process. This clinical trial will compare a supportive program called peer navigation, where trained individuals help families understand and engage with cancer treatment options, against regular care. The goal is to see if this support makes it easier for families to enroll their children in clinical trials and understand the consent process. The program includes four visits with a peer navigator who will assist families throughout their journey.

To participate in this study, parents must be Hispanic and have a child aged 0 to 17 who has recently been diagnosed with cancer or a similar condition and is eligible for a therapeutic clinical trial. Families will need to be comfortable discussing the study in English or Spanish and will be asked to sign a consent form. By joining, participants can expect personalized support and the opportunity to share their experiences, which will help improve the future of care for families facing similar challenges.

Gender

ALL

Eligibility criteria

• Participants (n≈400) will be parents of Hispanic children (0-17 years) with newly diagnosed cancer or cancer-like disease (histiocytic disorders or myelodysplastic syndromes) and eligible for a therapeutic clinical trial who meet the following inclusion criteria:
• • are a Hispanic parent/primary legal guardian;
• • has a child aged 0 to 17 y with a new diagnosis of cancer or cancer-like disease (histiocytic disorders or myelodysplastic syndromes);
• • has a child who is eligible for a therapeutic cancer clinical trial;
• • will participate in an informed consent discussion for the therapeutic clinical trial;
• • has an understanding of written and spoken English or Spanish;
• • has signed the consent form for the proposed COMPRENDO study.
• Parent Exclusion Criteria:
• • second malignancy/relapse;
• • diagnosed at an outside institution;
• • potential transfer of care to another institution within the next 4 months;
• • previously on a clinical trial;
• • does not understand written and spoken English or Spanish;
• • not Hispanic.
• Stakeholder Inclusion Criteria:
• • Clinicians and parents of children with cancer who have participated in IC discussion for a cancer therapeutic clinical trial.
• Stakeholder Exclusion Criteria:
• • Clinicians and parents of children with cancer who have not participated in IC discussion for a cancer therapeutic clinical trial.